Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

182.93 -0.15 (-0.08%)
Official Closing Price Updated: 5:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
71 72 Next >
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
The FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active Crohn's disease patients with inadequate response or intolerance to  
Via Benzinga
What Does AbbVie's Debt Look Like?
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Benzinga 
Via Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last... 
Via Benzinga
P/E Ratio Insights for AbbVie
Via Benzinga
Peering Into AbbVie's Recent Short Interest
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
This Analyst Likes Evolus As 'Top Play In Aesthetics'
Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S. 
Via Benzinga
Pfizer CEO Fires Back On US Drug Pricing Reforms: 'Negotiation with a Gun to Your Head'
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program "negotiation with a gun to your head."  
Via Benzinga
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Viking Therapeutics Stock Wobbled Today
The biotech's shares dipped along with the broader markets in early-morning trading today. 
Via The Motley Fool
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
Why Enanta Shares Are Plunging Today
Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded  
Via Benzinga
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope... 
Via Talk Markets
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
7 Dividend Stocks That Will Pay You Through Any Market Turmoil
With market conditions looking rather worrying, anxious investors turn to the best dividend stocks for market crash list. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Things About AbbVie That Investors Are Ignoring
AbbVie shares slipped following the latest earnings report. 
Via The Motley Fool
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
Look past the bad news, at how this company will perform in the future. 
Via The Motley Fool
Looking for Steady, Passive Income? Buy AbbVie Stock
The drugmaker looks poised to rebound from its Humira loss of exclusivity. 
Via The Motley Fool
3 Great Income Stocks That Retirees Should Love
If you're looking for additional retirement income, these three stocks should be right up your alley. 
Via The Motley Fool
7 Dividend-Paying Large-Cap Stocks to Buy in May
Here are some of the best dividend-paying large-cap stocks available that provide stability and income. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Analyst stock upgrades and downgrades caught the market's attention in the last week and putting investors on notice for buys and sells. 
Via InvestorPlace
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Vertex dominates the cystic fibrosis market today. 
Via The Motley Fool
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust. 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
3 of the Best High-Yielding Dividend Stocks to Buy in May
These dividend stocks are trading at cheap prices, and long-term investors should consider buying them right now. 
Via The Motley Fool
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
71 72 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.